I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN

Relative Value

The Relative Value of one IGN stock under the Base Case scenario is hidden PLN. Compared to the current market price of 5.04 PLN, Inno-Gene SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IGN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
5
Median 3Y
38.3
Median 5Y
13.2
Industry
4.3
vs History
vs Industry
4
Median 3Y
-2.9
Median 5Y
-2.7
Industry
34.1
vs History
vs Industry
100
Median 3Y
-18.7
Median 5Y
-6.5
Industry
20.8
vs History
vs Industry
2
Median 3Y
-16.8
Median 5Y
-7.4
Industry
27.9
vs History
23
vs Industry
14
Median 3Y
6.3
Median 5Y
4.2
Industry
3.1
vs History
6
vs Industry
5
Median 3Y
34.9
Median 5Y
10.6
Industry
4.3
vs History
vs Industry
37
Median 3Y
-79.1
Median 5Y
1.2
Industry
9.6
vs History
vs Industry
6
Median 3Y
-6.6
Median 5Y
-5.1
Industry
19.7
vs History
vs Industry
27
Median 3Y
-6.2
Median 5Y
-4.8
Industry
25.6
vs History
vs Industry
0
Median 3Y
-17
Median 5Y
-4.7
Industry
20.7
vs History
vs Industry
2
Median 3Y
-17
Median 5Y
-4.7
Industry
28.5
vs History
11
vs Industry
21
Median 3Y
4.6
Median 5Y
3.6
Industry
2.5

Multiples Across Competitors

IGN Competitors Multiples
Inno-Gene SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
Inno-Gene SA
WSE:IGN
17.7m PLN 38.3 -2.9 -6.6 -6.2
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 440.7 5 221.3 1 531.1 3 076
US
Thermo Fisher Scientific Inc
NYSE:TMO
233.6B USD 5.3 35.6 25.2 32.5
US
Danaher Corp
NYSE:DHR
166.7B USD 6.9 47.6 25.5 38.5
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.4 52.4 39.8 39.8
CN
WuXi AppTec Co Ltd
SSE:603259
298.3B CNY 6.7 19.9 20.2 20.2
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.5 31.5 15.1 22.7
US
Agilent Technologies Inc
NYSE:A
39.6B USD 5.7 30.4 23.5 28
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
29.8B USD 7.6 35.7 25.7 28.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.8B EUR 7 78.5 27.9 45.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
PL
I
Inno-Gene SA
WSE:IGN
Average EV/EBITDA: 175.1
Negative Multiple: -6.6
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 531.1
5%
306.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
25.2
6%
4.2
US
Danaher Corp
NYSE:DHR
25.5
5%
5.1
CH
Lonza Group AG
SIX:LONN
39.8
18%
2.2
CN
WuXi AppTec Co Ltd
SSE:603259
20.2
30%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
15.1
8%
1.9
US
Agilent Technologies Inc
NYSE:A
23.5
13%
1.8
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
25.7
4%
6.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.9
19%
1.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
PL
I
Inno-Gene SA
WSE:IGN
Average EV/EBIT: 335.5
Negative Multiple: -6.2
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 076
29%
106.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
32.5
15%
2.2
US
Danaher Corp
NYSE:DHR
38.5
16%
2.4
CH
Lonza Group AG
SIX:LONN
39.8
22%
1.8
CN
WuXi AppTec Co Ltd
SSE:603259
20.2
23%
0.9
US
IQVIA Holdings Inc
NYSE:IQV
22.7
15%
1.5
US
Agilent Technologies Inc
NYSE:A
28
23%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
22.5
28%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
28.5
5%
5.7
FR
Sartorius Stedim Biotech SA
PAR:DIM
45.8
31%
1.5